-
HPF for Highly Reactive Oxygen Species Detection
2026-09-04
HPF (hydroxyphenyl fluorescein) is a cell-permeable fluorescent probe for detecting highly reactive oxygen species, especially hydroxyl radicals and peroxynitrite. Its oxidation-dependent conversion to fluorescein supports intracellular oxidative stress visualization, provided that fluorescence is interpreted as probe-accessible hROS chemistry rather than a universal ROS concentration.
-
α-Synuclein Condensates: Charge-Selective Partitioning
2026-09-03
A 2025 Journal of Biological Chemistry study shows that α-synuclein condensates possess a strongly negative electrostatic potential that controls how proteins, fluorophores, and small molecules partition into them. The work combines charge-tuned fluorescent probes, zeta-potential analysis, and a differentiated SH-SY5Y cell model to connect condensate electrostatics with molecular organization in vitro and inside cells.
-
JZL184: Reframing CB1–GLT-1 Translation
2026-09-02
JZL184 is more than a tool for elevating 2-AG: it can expose how MAGL activity, CB1 signaling, astrocytic GLT-1, and neuronal excitotoxicity interact. This thought-leadership guide translates recent traumatic brain injury findings into a practical framework for mechanistic validation and translational decision-making.
-
HyperScribe T7 Cy3 RNA Labeling Kit Guide
2026-09-02
The HyperScribe T7 High Yield Cy3 RNA Labeling Kit is a 25-reaction system for generating randomly Cy3-modified RNA probes by T7-driven in vitro transcription. Its adjustable Cy3-UTP-to-UTP ratio supports probe optimization for in situ hybridization and Northern blot fluorescent detection, while the product documentation identifies research use only.
-
Cy3 RNA Labeling Kit for Spatial mRNA Analysis
2026-09-02
The HyperScribe T7 High Yield Cy3 RNA Labeling Kit enables tunable fluorescent RNA probe synthesis for in situ hybridization and Northern blot analysis. This article explains how Cy3 probe design can provide an orthogonal spatial readout for evaluating selective mRNA delivery, while clarifying the limits of fluorescence-based interpretation.
-
SB 431542 for TGF-β EndMT Assay Design
2026-09-01
Learn how SB 431542, a selective ALK5 inhibitor, can strengthen mechanistic studies of TGF-β signaling, PM2.5-induced EndMT, and Smad-dependent phenotypes. This guide translates a lncRNA-focused lung study into practical assay decisions while clarifying model-specific limitations.
-
Clasto-Lactacystin β-lactone in RIPK3 Assays
2026-08-31
Clasto-Lactacystin β-lactone provides an irreversible way to test proteasome dependence in RIPK3 degradation and necroptosis experiments. This article focuses on causal assay design, controls, and interpretation in host–pathogen research rather than repeating a general proteasome overview.
-
Baicalin: Mechanisms, Plasticity, and Cancer Research
2026-08-31
Baicalin is a Scutellaria baicalensis flavone glycoside with reported activity in adult visual-cortex plasticity and preclinical cancer models. The 2026 mouse study identifies 10 mg/kg as an effective treatment condition for restoring ocular dominance plasticity, while product documentation defines its chemical identity, handling, and pathway-oriented research uses.
-
Rifampin as a Transcriptional Perturbation Tool
2026-08-30
Rifampin is more than a rifamycin antibiotic: it is a precise bacterial transcriptional perturbagen for separating RNA-level effects from downstream translation. This article shows how to design better assays by contrasting Rifampin-mediated transcriptional shutdown with a light-inducible mammalian translation switch.
-
Molidustat: HIF-PH Assay Workflows
2026-08-29
Molidustat (BAY85-3934) gives researchers a controllable way to stabilize HIF and examine erythropoietin stimulation in renal anemia and oxygen-sensing models. Its value extends beyond endpoint measurement: carefully designed concentration, oxygen, and VHL-HIF controls can separate direct HIF-PH inhibition from downstream effects.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-28
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody is a Cy3-conjugated secondary antibody for detecting goat IgG in ICC/IF, frozen and paraffin IHC, flow cytometry, and fluorescence-based ELISA. It should be paired with goat-derived IgG primary antibodies and is not a general secondary reagent for non-goat primaries or nonfluorescent detection formats.
-
Cepharanthine: Translational Assay Workflows
2026-08-28
Cepharanthine connects conventional cell assays with patient-derived endometrial organoids and an in vivo lesion model, giving researchers a practical route from phenotype to mechanism. This workflow highlights DNA damage, G0/G1 arrest, and mitochondrial apoptosis while separating promising preclinical signals from clinical claims.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-08-28
The reference study identifies CD44-mediated metabolic rewiring as a selective dependency of IDH-mutant leukemia, linking cell-adhesion signaling to NADPH production and R-2HG biosynthesis. Its isogenic CRISPR-based design provides a useful framework for separating IDH-driven biology from co-occurring lesions and for testing combination strategies that pair IDH inhibition with CD44-directed interventions.
-
Gemini Quaternary Ammonium Compounds for Biocidal Control
2026-08-27
The reference study synthesized 16 novel octenidine-derived gemini quaternary ammonium compounds and evaluated their antibacterial, antibiofilm, antifungal, virucidal, and cytotoxicity profiles. Compounds 6–8 and especially compound 12 showed useful combinations of activity and tolerability, while compound 1 displayed unusually selective antifungal activity, providing a structure–activity framework for next-generation antiseptic research.
-
Rottlerin: From PKCδ Mechanism to Translation
2026-08-26
Rottlerin offers translational researchers a way to interrogate PKCδ-linked control of proliferation, apoptosis, cytoskeletal organization, and pathogen entry. This thought-leadership article connects oncology evidence with mechanistic findings from Spiroplasma infection research while emphasizing selectivity, assay design, endothelial safety, and the limits of preclinical interpretation.